搜索临床试验以:YKL-40
总计3065个结果
-
Zealand University HospitalUniversity of Copenhagen; Region Zealand未知
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
Tehran University of Medical Sciences完全的
-
Shahid Beheshti University of Medical SciencesPooyesh Darou完全的
-
Universitätsklinikum Hamburg-EppendorfAbbott Medical Devices; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)完全的
-
Meir Medical CenterClalit Health Services; Reidman college未知
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止输卵管腺癌 | 输卵管移行细胞癌 | 卵巢腺癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 恶性卵巢布伦纳瘤 | 原发性腹膜浆液性腺癌 | 恶性卵巢透明细胞瘤 | 恶性卵巢子宫内膜样瘤 | 恶性卵巢粘液性肿瘤 | 恶性卵巢混合性上皮瘤 | 未分化卵巢癌 | IIIA 期输卵管癌 | IIIA期卵巢癌 | IIIA 期原发性腹膜癌 | IIIB 期输卵管癌 | IIIB期卵巢癌 | IIIB 期原发性腹膜癌 | IIIC 期输卵管癌 | IIIC 期卵巢癌 | IIIC 期原发性腹膜癌 | IV 期输卵管癌 | IV 期卵巢癌 | IV 期原发性腹膜癌 | 恶性卵巢肿瘤 | 恶性卵巢浆液性肿瘤 | 恶性卵巢移行细胞瘤 | 未分化输卵管癌美国
-
Laval University完全的
-
Wuling OuJiangsu HengRui Medicine Co., Ltd.; Hubei Clinical Research Collaboration Group未知
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France完全的
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZeneca完全的
-
Duke UniversityAmerican Heart Association终止
-
Centre Hospitalier Intercommunal Creteil主动,不招人
-
MedtronicNeuroMedtronic Bakken Research Center完全的
-
Betsi Cadwaladr University Health BoardOxford Brookes University招聘中
-
Novartis Pharmaceuticals完全的
-
University of SouthamptonBioNTech SE完全的
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical Trials完全的
-
Aarhus University HospitalOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark; Bispebjerg Hospital 和其他合作者完全的